Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543133 | SCV000645745 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-11-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170586 | SCV001333174 | likely benign | Cardiomyopathy | 2018-02-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528319 | SCV001903378 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367884 | SCV002658989 | likely benign | Cardiovascular phenotype | 2019-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV001528319 | SCV001739869 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700411 | SCV001923192 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528319 | SCV001929818 | likely benign | not provided | no assertion criteria provided | clinical testing |